Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NT 201 for combined treatment of upper facial lines
2011-005887-20Phase 3Completed
- Sponsor
- Merz
- Start
- May 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Forehead lines and glabellar furrowing comparing NT 201 with Placebo (2 arms). Started May 2012; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Forehead linesglabellar furrowing
Beyond the preview
Go deeper on 2011-005887-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005887-20.